Swiss biotech scaling high-throughput RNA sequencing kits for drug discovery and toxicology.
| Date | Round | Amount |
|---|---|---|
| Mar 2026 | Seed Swiss Alithea Genomics closed a CHF 6.9M ($8.9M) seed round to scale its high-throughput RNA sequencing technology. | $8.9M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.